COMMUNIQUÉS West-GlobeNewswire

Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
28/01/2019
Actigraphy is Being Utilized to Evaluate Multiple Clinically Meaningful Activity Parameters in the Ongoing INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung [...]
New Clinical Trial Finds Milestone Scientific’s CompuFlo® Instrument a Safe Alternative to Current Standards of Care
28/01/2019
Publication in top ranked Anesthesia & Analgesia Journal compares CompuFlo pressure sensing to fluoroscopy and loss of resistance LIVINGSTON, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: [...]
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy
28/01/2019
Allogene to Initiate the ALPHA Study for ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma ALLO-647, Allogene’s Proprietary anti-CD52 Antibody, Will be Administered as Part of the Lymphodepletion Regimen SOUTH SAN [...]
How Cannabinoids Could Replace Opioids -- CFN Media
28/01/2019
SEATTLE, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
BioTelemetry, Inc. to Acquire Geneva Healthcare, Inc.
28/01/2019
Creates Most Comprehensive Connected Health Solution in Cardiology Market MALVERN, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company [...]
Advantis Corp. Says Orders Doubled to Start the Year
28/01/2019
NEWPORT BEACH, CA, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that orders from existing customers are already double that of the fourth quarter. Advantis [...]
Summit Healthcare selects 2bPrecise for Pharmacogenomics
28/01/2019
Arizona-based provider launches precision medicine initiative for improved outcomes and patient experience CHICAGO and PITTSBURGH and SHOW LOW, Ariz., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, [...]
electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference
28/01/2019
BASKING RIDGE, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced Chief Executive Officer, Frank Amato and Chief [...]
Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement
28/01/2019
ALPHARETTA, Ga., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on January 18, 2019, the Company entered into a securities purchase agreement with [...]
Israel Passes Cannabis Export Law, Paving Path for Aura’s European Distribution
28/01/2019
TORONTO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased with the final approval of Israel’s export law for medical cannabis. On Sunday, January 27, the Israeli [...]
Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
28/01/2019
REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Pantheris® SV (Small [...]
Xenon Provides Key Regulatory Updates on XEN007 and XEN1101
28/01/2019
FDA Grants Rare Pediatric Disease Designation to XEN007 for Alternating Hemiplegia of Childhood (AHC); Xenon Eligible to Apply for Priority Review Voucher IND for XEN1101 Accepted; Site Selection and Patient Enrollment [...]
Chiesi in the Community Donates approximately $850,000 in 2018
28/01/2019
The company’s CSR efforts amplified by investing in the local community and therapeutic areas CARY, N.C., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee) , a Cary-based specialty pharmaceutical company, [...]
BLVD Centers Announces Disposition of Outpatient Centers for Net Proceeds of $5,500,000; Executes Letters of Intent for Two Potential Cannabis Acquisitions With Revenues Totaling $2,700,000 Annually
28/01/2019
Posts Third Quarter Financials; Reports Cash Increase of $665,000 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BLVD [...]
Avalon GloboCare and its Subsidiary Genexosome Technologies Announce Discovery and Development of World’s First Saliva-Based Exosomal Biomarker “miR-185” as Dual Diagnostic and Therapeutic Target for Oral Cancer
28/01/2019
Study Accepted as Poster Presentation at the 8 th Annual Meeting of the International Society for Extracellular Vesicles (ISEV 2019) Publication of PCT Patent Application Covering a Method for Preventing and Treating [...]
Tauriga Sciences, Inc. Fully Satisfies its Financial Obligations Pursuant to Tauri-Gum Manufacturing Agreement
28/01/2019
Company Has Paid in Full for Entire Initial Production Run of its CBD Infused Chewing Gum; Branded as Tauri-Gum TM NEW YORK, NY, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG [...]
Wellness Matrix Group Files Required Disclosures with OTC Markets
28/01/2019
LOS ANGELES, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix Group, Inc. (OTC PINK: WMGR), which is developing technologically advanced virtual reality and artificial intelligence utilizing healthcare platform models [...]
Nicotine dependence is an increasing problem
28/01/2019
Press release 28 th of January 2019 Nicotine dependence is an increasing health problem even if smoking itself shows a declining trend. Nicotine-containing products frequently remain “on” even for years after smoking [...]
Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
28/01/2019
SAN DIEGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced publications expanding on previously reported results from three of the company’s completed Phase 2 clinical trials [...]

Pages